Agnieszka Filipek

Dr. Agnieszka Filipek

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Phytomedicine
Verified
Journal Article
Closed access
AKAnna Karolina Kiss
Anna Karolina Kiss
ABAgnieszka Bazylko
Agnieszka Bazylko
Agnieszka FilipekAgnieszka Filipek
Agnieszka Filipek
Sebastian GranicaSebastian Granica
Sebastian Granica
EJEdyta Jaszewska
Edyta Jaszewska
JPJakub Patryk Piwowarski
Jakub Patryk Piwowarski

1 December 2015 in Phytomedicine
Verified
Journal Article
Closed access
Agnieszka FilipekAgnieszka Filipek
Agnieszka Filipek
Monika CzerwińskaMonika Czerwińska
Monika Czerwińska
AKAnna Karolina Kiss
Anna Karolina Kiss
Małgorzata WrzosekMałgorzata Wrzosek
Małgorzata Wrzosek
MNMarek Naruszewicz
Marek Naruszewicz

1 August 2013 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ABAgnieszka Bazylko
Agnieszka Bazylko
JPJakub Patryk Piwowarski
Jakub Patryk Piwowarski
Agnieszka FilipekAgnieszka Filipek
Agnieszka Filipek
JBJessica Bonarewicz
Jessica Bonarewicz
Michał TomczykMichał Tomczyk
Michał Tomczyk

1 August 2017 in Phytomedicine
Verified
Journal Article
Closed access
Agnieszka FilipekAgnieszka Filipek
Agnieszka Filipek
Monika CzerwińskaMonika Czerwińska
Monika Czerwińska
AKAnna Karolina Kiss
Anna Karolina Kiss
JPJerzy A. Polański
Jerzy A. Polański
MNMarek Naruszewicz
Marek Naruszewicz

1 October 2013 in Industrial Crops and Products
Verified
Journal Article
Closed access
ABAgnieszka Bazylko
Agnieszka Bazylko
Sebastian GranicaSebastian Granica
Sebastian Granica
Agnieszka FilipekAgnieszka Filipek
Agnieszka Filipek
JPJakub Patryk Piwowarski
Jakub Patryk Piwowarski
JSJoanna Stefańska
Joanna Stefańska
AKAnna Karolina Kiss
Anna Karolina Kiss

24 April 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
BMBarbara Michalak
Barbara Michalak
Agnieszka FilipekAgnieszka Filipek
Agnieszka Filipek
PCPiotr Chomicki
Piotr Chomicki
MPMałgorzata Pyza
Małgorzata Pyza
MWMarta Woźniak
Marta Woźniak
AKAnna Karolina Kiss
Anna Karolina Kiss
Aim of the study: Taking into account that overactivated leukocytes are an important factor in the development of many chronic diseases, we investigated the activity of phytochemically characterized (HPLC-DAD-MSn) extracts from forsythia leaves and flowers on the pro- and anti-inflammatory functions of leukocytes (effects on IL-1β, IL-8, TNF-α, and TGFβ release) and their adherence to endothelial cells. Using bio-guided fractionation, we isolated the active compounds and determined their biological activity, and we included the positive control quercetin. Methods: The effect on IL-1β, TNF-α, IL-8, and TGF-α production by leukocytes was measured by enzyme-linked immunosorbent assay (ELISA). The surface expression of adhesion molecules was analyzed with flow cytometry, and the neutrophil attachment to the endothelial cells was assessed fluorimetrically. The effects on p38MAPK, ERK1/2 and JNK phosphorylation were determined using western blots. Results: Leaf extracts had the effect of decreasing TNF-α production in neutrophils and monocyte/macrophage cells. The bio-guided fractionation led to the isolation of the following lignan aglycones: (+)-pinoresinol, (+)-epipinoresinol, (−)-matairesinol, (+)-phillygenin, and (−)-arctigenin. Only phillygenin was able to stimulate the anti-inflammatory function of macrophages by inducing TGF-β release and IL-10 receptor surface expression. Arctigenin, phillygenin, and a metabolite produced by the gut microbiota, enterolactone, decreased TNF-α and IL-1β production and neutrophil adhesion to endothelial cells, probably by attenuating the p38 and ERK kinase pathways. Conclusion: Forsythia x intermedia is a valuable source of active lignans, which may be potential candidates for treating inflammatory diseases that are associated with the excessive production of cytokines such as TNF-α and IL-1β.